Cardiovascular Diseases Clinical Trials in Lexington, Kentucky
5 studies are recruiting for cardiovascular diseases in Lexington, Kentucky right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglif…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- The Research Group of Lexington, Lexington, Kentucky
- Locations
- 1143 in total
- Run by
- Boehringer Ingelheim
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- University of Kentucky, Lexington, Kentucky
- Locations
- 47 in total
- Run by
- BrioHealth Solutions, Inc.
-
Cardiovascular Biorepository
Use biospecimens procured from patients and organ donors to improve understanding of molecular, cellular, and tissue-level processes produced by cardiovascular disease and therapeutic interventions
- Stage
- Not phased
- Ages
- Any age
- Site
- University of Kentucky, Department of Internal Medicine, Division of Cardiovascular Medicine, Lexington, Kentucky
- Run by
- Kenneth S. Campbell
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Kentucky, Lexington, Kentucky
- Locations
- 68 in total
- Run by
- Abbott Medical Devices
-
Biopsy Collection and Repository Database
Use samples procured from patients to improve understanding of molecular, cellular, and tissue-level processes produced by a variety of cardiac diseases and therapeutic interventions.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Kentucky, Lexington, Kentucky
- Run by
- Kenneth S. Campbell
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.